Approval · Notice of Compliance 9079 · 2007
DOVONEX: Notice of Compliance 9079
Issued October 11, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9079
- Date
- October 11, 2007
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Amend indication to remove combination use with phototherapy
- Therapeutic class
- Non-steroidal antipsoriatic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOVONEX | Not yet assigned | — |
Medicinal ingredients
- CALCIPOTRIOL 50 MCG per G
- CALCIPOTRIOL 50 MCG per ML